20th Jun 2006 11:37
AGI Therapeutics plc20 June 2006 AGI Therapeutics plc ("AGI" or the "Company") Further information on Director Appointment The following disclosure is made in relation to the appointment of Dr. DavidYoung as Director of AGI and President of US Operations. Dr. Young has been a director of the following companies in the past five year: Current Directorships Previous DirectorshipsGBM Holdings LLC GloboMax Holdings LLC DKBK Enterprise LLC GloboMax LLC GloboAsia LLC GloboMax Americas LLC GloboMax Europe LLC There are no details that are required to be disclosed under Schedule 2,paragraph (g) of the AIM and IEX Rules. Contact Information: David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 20 June, 2006 This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai